Catheter Precision, Inc.
VTAK · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $420 | $442 | $14 | $22 |
| % Growth | -5% | 3,057.1% | -36.4% | – |
| Cost of Goods Sold | $42 | $30 | $161 | $1,560 |
| Gross Profit | $378 | $412 | -$147 | -$1,538 |
| % Margin | 90% | 93.2% | -1,050% | -6,990.9% |
| R&D Expenses | $272 | $475 | $6,392 | $12,253 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $11,349 | $17,122 | $16,250 | $15,475 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $60,934 | $4,172 | $0 |
| Operating Expenses | $11,621 | $78,531 | $26,814 | $27,728 |
| Operating Income | -$11,243 | -$78,119 | -$26,961 | -$29,266 |
| % Margin | -2,676.9% | -17,674% | -192,578.6% | -133,027.3% |
| Other Income/Exp. Net | -$2,259 | $7,547 | $99 | $2,009 |
| Pre-Tax Income | -$13,502 | -$70,572 | -$26,862 | -$27,257 |
| Tax Expense | $3,141 | $0 | $3 | $4 |
| Net Income | -$16,643 | -$70,572 | -$26,865 | -$25,070 |
| % Margin | -3,962.6% | -15,966.5% | -191,892.9% | -113,954.5% |
| EPS | -6.68 | -12.99 | -25.98 | -248.22 |
| % Growth | 48.6% | 50% | 89.5% | – |
| EPS Diluted | -6.68 | -12.99 | -25.98 | -248.22 |
| Weighted Avg Shares Out | 3,264 | 5,495 | 1,034 | 101 |
| Weighted Avg Shares Out Dil | 3,264 | 5,495 | 1,034 | 101 |
| Supplemental Information | – | – | – | – |
| Interest Income | $81 | $347 | $0 | $0 |
| Interest Expense | $91 | $0 | $0 | $10 |
| Depreciation & Amortization | $2,109 | $2,075 | $421 | $1,400 |
| EBITDA | -$11,302 | -$15,110 | -$22,368 | -$25,847 |
| % Margin | -2,691% | -3,418.6% | -159,771.4% | -117,486.4% |